Our website is made possible by displaying online advertisements to our visitors.
Please consider supporting us by disabling your ad blocker.

PHARMA

Quarterly rpt on consolidated results for the financial period ended 30 Sep 2018

PHARMANIAGA BERHAD

Financial Year End 31 Dec 2018
Quarter 3 Qtr
Quarterly report for the financial period ended 30 Sep 2018
The figures have not been audited

Attachments

Pharma Q3 2018.pdf
263.8 kB

  • Default Currency
  • Other Currency

Currency: Malaysian Ringgit (MYR)

SUMMARY OF KEY FINANCIAL INFORMATION
30 Sep 2018

 
INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR
CORRESPONDING
QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR
CORRESPONDING
PERIOD
30 Sep 2018
30 Sep 2017
30 Sep 2018
30 Sep 2017
$$'000
$$'000
$$'000
$$'000
1 Revenue
587,660
574,503
1,788,312
1,710,764
2 Profit/(loss) before tax
17,603
15,271
58,280
53,198
3 Profit/(loss) for the period
15,305
3,890
38,660
32,899
4 Profit/(loss) attributable to ordinary equity holders of the parent
15,051
3,580
38,031
32,023
5 Basic earnings/(loss) per share (Subunit)
5.79
1.38
14.63
12.34
6 Proposed/Declared dividend per share (Subunit)
5.00
5.00
14.00
13.00


AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
Net assets per share attributable to ordinary equity holders of the parent ($$)
2.0100
2.0300

Definition of Subunit:

In a currency system, there is usually a main unit (base) and subunit that is a fraction amount of the main unit.
Example for the subunit as follows:

Country Base Unit Subunit
Malaysia Ringgit Sen
United States Dollar Cent
United Kingdom Pound Pence




Announcement Info

Company Name PHARMANIAGA BERHAD
Stock Name PHARMA
Date Announced 19 Nov 2018
Category Financial Results
Reference Number FRA-14112018-00015